[Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2].
Identifieur interne : 000029 ( Main/Exploration ); précédent : 000028; suivant : 000030[Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2].
Auteurs : A. Sauvaget [France] ; R. Dumont [France] ; N. Bukowski [France] ; O. Bonnot [France] ; R. Auffret [France] ; E. Poulet [France] ; D. Szekely [France] ; C. Quiles [France] ; A. Yrondi [France] ; M. Plaze [France] ; W. De Carvalho [France] ; A. Amad [France] ; S. Bulteau [France]Source :
- L'Encephale [ 0013-7006 ] ; 2020.
Descripteurs français
- KwdFr :
- Contrôle des maladies contagieuses (législation et jurisprudence), Contrôle des maladies contagieuses (méthodes), Dispositifs de protection, France, Guides de bonnes pratiques cliniques comme sujet, Humains, Hôpitaux privés, Hôpitaux publics, Infections à coronavirus (prévention et contrôle), Infections à coronavirus (transmission), Isolement social, Maisons de repos, Pandémies (prévention et contrôle), Pneumopathie virale (prévention et contrôle), Pneumopathie virale (transmission), Sécurité des patients, Sélection de patients, Électroconvulsivothérapie (méthodes), Électroconvulsivothérapie (normes).
- MESH :
- législation et jurisprudence : Contrôle des maladies contagieuses.
- méthodes : Contrôle des maladies contagieuses, Électroconvulsivothérapie.
- normes : Électroconvulsivothérapie.
- prévention et contrôle : Infections à coronavirus, Pandémies, Pneumopathie virale.
- Dispositifs de protection, France, Guides de bonnes pratiques cliniques comme sujet, Humains, Hôpitaux privés, Hôpitaux publics, Infections à coronavirus, Isolement social, Maisons de repos, Pneumopathie virale, Sécurité des patients, Sélection de patients.
- Wicri :
- geographic : France.
English descriptors
- KwdEn :
- Betacoronavirus, Communicable Disease Control (legislation & jurisprudence), Communicable Disease Control (methods), Coronavirus Infections (prevention & control), Coronavirus Infections (transmission), Electroconvulsive Therapy (methods), Electroconvulsive Therapy (standards), France, Hospitals, Private, Hospitals, Public, Humans, Nursing Homes, Pandemics (prevention & control), Patient Safety, Patient Selection, Pneumonia, Viral (prevention & control), Pneumonia, Viral (transmission), Practice Guidelines as Topic, Procedures and Techniques Utilization, Protective Devices, Social Isolation.
- MESH :
- geographic : France.
- legislation & jurisprudence : Communicable Disease Control.
- methods : Communicable Disease Control, Electroconvulsive Therapy.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- standards : Electroconvulsive Therapy.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- Betacoronavirus, Hospitals, Private, Hospitals, Public, Humans, Nursing Homes, Patient Safety, Patient Selection, Practice Guidelines as Topic, Procedures and Techniques Utilization, Protective Devices, Social Isolation.
Abstract
The COVID-19 pandemic has had major consequences for the organization of care. In France and around the world, centers practicing electroconvulsive therapy (ECT) have seen their activity decrease, or even stop for many reasons. In this context, maintaining or resuming this essential therapeutic activity for many patients suffering from psychiatric disorders requires material, human and logistical adaptations that should be supervised. The objective of this collective and national work is to offer simple recommendations that can be applied immediately by any healthcare establishment, public or private, practicing ECT. They are the result of feedback from multiprofessional and inter-establishment experiences. Declined in three stages, these recommendations are accompanied by a practical sheet which describes in detail the necessary conditions and prerequisites for any resumption of ECT activity.
DOI: 10.1016/j.encep.2020.05.008
PubMed: 32507557
PubMed Central: PMC7271849
Affiliations:
- France
- Aquitaine, Auvergne-Rhône-Alpes, Hauts-de-France, Midi-Pyrénées, Nord-Pas-de-Calais, Nouvelle-Aquitaine, Occitanie (région administrative), Pays de la Loire, Rhône-Alpes, Île-de-France
- Bordeaux, Lille, Lyon, Meudon, Nantes, Paris, Toulouse
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2].</title><author><name sortKey="Sauvaget, A" sort="Sauvaget, A" uniqKey="Sauvaget A" first="A" last="Sauvaget">A. Sauvaget</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Nantes Université, CHU Nantes, Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France. Electronic address: anne.sauvaget@chu-nantes.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Nantes Université, CHU Nantes, Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Dumont, R" sort="Dumont, R" uniqKey="Dumont R" first="R" last="Dumont">R. Dumont</name><affiliation wicri:level="3"><nlm:affiliation>CHU de Nantes, Department of Anesthesiology and Critical Care Medicine, Hôtel-Dieu-PTMC, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHU de Nantes, Department of Anesthesiology and Critical Care Medicine, Hôtel-Dieu-PTMC, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Bukowski, N" sort="Bukowski, N" uniqKey="Bukowski N" first="N" last="Bukowski">N. Bukowski</name><affiliation wicri:level="3"><nlm:affiliation>CHU Nantes, Department of Addictology and Psychiatry, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHU Nantes, Department of Addictology and Psychiatry, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Bonnot, O" sort="Bonnot, O" uniqKey="Bonnot O" first="O" last="Bonnot">O. Bonnot</name><affiliation wicri:level="3"><nlm:affiliation>Child and Adolescent Psychiatry Department, CHU and University of Nantes, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Child and Adolescent Psychiatry Department, CHU and University of Nantes, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Auffret, R" sort="Auffret, R" uniqKey="Auffret R" first="R" last="Auffret">R. Auffret</name><affiliation wicri:level="3"><nlm:affiliation>CHU Nantes, Department of Addictology and Psychiatry, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHU Nantes, Department of Addictology and Psychiatry, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Poulet, E" sort="Poulet, E" uniqKey="Poulet E" first="E" last="Poulet">E. Poulet</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Centre hospitalier Le Vinatier, Bron, France; Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 69000 Lyon, France; University Lyon 1, 69000 Villeurbanne, France; Department of Emergency Psychiatry, hospices civils de Lyon, University Hospital Edouard-Herriot, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Centre hospitalier Le Vinatier, Bron, France; Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 69000 Lyon, France; University Lyon 1, 69000 Villeurbanne, France; Department of Emergency Psychiatry, hospices civils de Lyon, University Hospital Edouard-Herriot, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Szekely, D" sort="Szekely, D" uniqKey="Szekely D" first="D" last="Szekely">D. Szekely</name><affiliation wicri:level="1"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Department of psychiatry, centre hospitalier Princesse-Grace, 98000 Monaco, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Department of psychiatry, centre hospitalier Princesse-Grace, 98000 Monaco</wicri:regionArea><wicri:noRegion>98000 Monaco</wicri:noRegion><wicri:noRegion>98000 Monaco</wicri:noRegion></affiliation></author><author><name sortKey="Quiles, C" sort="Quiles, C" uniqKey="Quiles C" first="C" last="Quiles">C. Quiles</name><affiliation wicri:level="3"><nlm:affiliation>Centre hospitalier Charles-Perrens, 33000 Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre hospitalier Charles-Perrens, 33000 Bordeaux</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Yrondi, A" sort="Yrondi, A" uniqKey="Yrondi A" first="A" last="Yrondi">A. Yrondi</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Service de psychiatrie et de psychologie médicale, centre expert dépression résistante fondamental, CHU de Toulouse, Toulouse, France; Inserm, UPS, ToNIC Toulouse NeuroImaging Center, hôpital Purpan, université de Toulouse, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Service de psychiatrie et de psychologie médicale, centre expert dépression résistante fondamental, CHU de Toulouse, Toulouse, France; Inserm, UPS, ToNIC Toulouse NeuroImaging Center, hôpital Purpan, université de Toulouse, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Plaze, M" sort="Plaze, M" uniqKey="Plaze M" first="M" last="Plaze">M. Plaze</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Université de Paris, 75005 Paris, France; Service hospitalo-universitaire, GHU de Paris psychiatrie & neurosciences, 75014 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Université de Paris, 75005 Paris, France; Service hospitalo-universitaire, GHU de Paris psychiatrie & neurosciences, 75014 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="De Carvalho, W" sort="De Carvalho, W" uniqKey="De Carvalho W" first="W" last="De Carvalho">W. De Carvalho</name><affiliation wicri:level="3"><nlm:affiliation>Pôle ECT - groupe SINOUÉ, clinique BELLEVUE, 92190 Meudon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pôle ECT - groupe SINOUÉ, clinique BELLEVUE, 92190 Meudon</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Meudon</settlement></placeName></affiliation></author><author><name sortKey="Amad, A" sort="Amad, A" uniqKey="Amad A" first="A" last="Amad">A. Amad</name><affiliation wicri:level="3"><nlm:affiliation>Inserm, U1172 - LilNCog - Lille Neuroscience & Cognition, CHU de Lille, université de Lille, 59000 Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1172 - LilNCog - Lille Neuroscience & Cognition, CHU de Lille, université de Lille, 59000 Lille</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author><author><name sortKey="Bulteau, S" sort="Bulteau, S" uniqKey="Bulteau S" first="S" last="Bulteau">S. Bulteau</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; CHU Nantes, Department of Addictology and Psychiatry, Nantes, France; Inserm-U1246 SPHERE University of Nantes and University of Tours, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; CHU Nantes, Department of Addictology and Psychiatry, Nantes, France; Inserm-U1246 SPHERE University of Nantes and University of Tours, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32507557</idno><idno type="pmid">32507557</idno><idno type="doi">10.1016/j.encep.2020.05.008</idno><idno type="pmc">PMC7271849</idno><idno type="wicri:Area/Main/Corpus">000641</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000641</idno><idno type="wicri:Area/Main/Curation">000641</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000641</idno><idno type="wicri:Area/Main/Exploration">000641</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2].</title><author><name sortKey="Sauvaget, A" sort="Sauvaget, A" uniqKey="Sauvaget A" first="A" last="Sauvaget">A. Sauvaget</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Nantes Université, CHU Nantes, Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France. Electronic address: anne.sauvaget@chu-nantes.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Nantes Université, CHU Nantes, Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Dumont, R" sort="Dumont, R" uniqKey="Dumont R" first="R" last="Dumont">R. Dumont</name><affiliation wicri:level="3"><nlm:affiliation>CHU de Nantes, Department of Anesthesiology and Critical Care Medicine, Hôtel-Dieu-PTMC, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHU de Nantes, Department of Anesthesiology and Critical Care Medicine, Hôtel-Dieu-PTMC, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Bukowski, N" sort="Bukowski, N" uniqKey="Bukowski N" first="N" last="Bukowski">N. Bukowski</name><affiliation wicri:level="3"><nlm:affiliation>CHU Nantes, Department of Addictology and Psychiatry, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHU Nantes, Department of Addictology and Psychiatry, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Bonnot, O" sort="Bonnot, O" uniqKey="Bonnot O" first="O" last="Bonnot">O. Bonnot</name><affiliation wicri:level="3"><nlm:affiliation>Child and Adolescent Psychiatry Department, CHU and University of Nantes, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Child and Adolescent Psychiatry Department, CHU and University of Nantes, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Auffret, R" sort="Auffret, R" uniqKey="Auffret R" first="R" last="Auffret">R. Auffret</name><affiliation wicri:level="3"><nlm:affiliation>CHU Nantes, Department of Addictology and Psychiatry, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHU Nantes, Department of Addictology and Psychiatry, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Poulet, E" sort="Poulet, E" uniqKey="Poulet E" first="E" last="Poulet">E. Poulet</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Centre hospitalier Le Vinatier, Bron, France; Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 69000 Lyon, France; University Lyon 1, 69000 Villeurbanne, France; Department of Emergency Psychiatry, hospices civils de Lyon, University Hospital Edouard-Herriot, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Centre hospitalier Le Vinatier, Bron, France; Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 69000 Lyon, France; University Lyon 1, 69000 Villeurbanne, France; Department of Emergency Psychiatry, hospices civils de Lyon, University Hospital Edouard-Herriot, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Szekely, D" sort="Szekely, D" uniqKey="Szekely D" first="D" last="Szekely">D. Szekely</name><affiliation wicri:level="1"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Department of psychiatry, centre hospitalier Princesse-Grace, 98000 Monaco, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Department of psychiatry, centre hospitalier Princesse-Grace, 98000 Monaco</wicri:regionArea><wicri:noRegion>98000 Monaco</wicri:noRegion><wicri:noRegion>98000 Monaco</wicri:noRegion></affiliation></author><author><name sortKey="Quiles, C" sort="Quiles, C" uniqKey="Quiles C" first="C" last="Quiles">C. Quiles</name><affiliation wicri:level="3"><nlm:affiliation>Centre hospitalier Charles-Perrens, 33000 Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre hospitalier Charles-Perrens, 33000 Bordeaux</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Yrondi, A" sort="Yrondi, A" uniqKey="Yrondi A" first="A" last="Yrondi">A. Yrondi</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Service de psychiatrie et de psychologie médicale, centre expert dépression résistante fondamental, CHU de Toulouse, Toulouse, France; Inserm, UPS, ToNIC Toulouse NeuroImaging Center, hôpital Purpan, université de Toulouse, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Service de psychiatrie et de psychologie médicale, centre expert dépression résistante fondamental, CHU de Toulouse, Toulouse, France; Inserm, UPS, ToNIC Toulouse NeuroImaging Center, hôpital Purpan, université de Toulouse, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Plaze, M" sort="Plaze, M" uniqKey="Plaze M" first="M" last="Plaze">M. Plaze</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Université de Paris, 75005 Paris, France; Service hospitalo-universitaire, GHU de Paris psychiatrie & neurosciences, 75014 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Université de Paris, 75005 Paris, France; Service hospitalo-universitaire, GHU de Paris psychiatrie & neurosciences, 75014 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="De Carvalho, W" sort="De Carvalho, W" uniqKey="De Carvalho W" first="W" last="De Carvalho">W. De Carvalho</name><affiliation wicri:level="3"><nlm:affiliation>Pôle ECT - groupe SINOUÉ, clinique BELLEVUE, 92190 Meudon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pôle ECT - groupe SINOUÉ, clinique BELLEVUE, 92190 Meudon</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Meudon</settlement></placeName></affiliation></author><author><name sortKey="Amad, A" sort="Amad, A" uniqKey="Amad A" first="A" last="Amad">A. Amad</name><affiliation wicri:level="3"><nlm:affiliation>Inserm, U1172 - LilNCog - Lille Neuroscience & Cognition, CHU de Lille, université de Lille, 59000 Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1172 - LilNCog - Lille Neuroscience & Cognition, CHU de Lille, université de Lille, 59000 Lille</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author><author><name sortKey="Bulteau, S" sort="Bulteau, S" uniqKey="Bulteau S" first="S" last="Bulteau">S. Bulteau</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; CHU Nantes, Department of Addictology and Psychiatry, Nantes, France; Inserm-U1246 SPHERE University of Nantes and University of Tours, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; CHU Nantes, Department of Addictology and Psychiatry, Nantes, France; Inserm-U1246 SPHERE University of Nantes and University of Tours, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author></analytic><series><title level="j">L'Encephale</title><idno type="ISSN">0013-7006</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus</term><term>Communicable Disease Control (legislation & jurisprudence)</term><term>Communicable Disease Control (methods)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (transmission)</term><term>Electroconvulsive Therapy (methods)</term><term>Electroconvulsive Therapy (standards)</term><term>France</term><term>Hospitals, Private</term><term>Hospitals, Public</term><term>Humans</term><term>Nursing Homes</term><term>Pandemics (prevention & control)</term><term>Patient Safety</term><term>Patient Selection</term><term>Pneumonia, Viral (prevention & control)</term><term>Pneumonia, Viral (transmission)</term><term>Practice Guidelines as Topic</term><term>Procedures and Techniques Utilization</term><term>Protective Devices</term><term>Social Isolation</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Contrôle des maladies contagieuses (législation et jurisprudence)</term><term>Contrôle des maladies contagieuses (méthodes)</term><term>Dispositifs de protection</term><term>France</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Hôpitaux privés</term><term>Hôpitaux publics</term><term>Infections à coronavirus (prévention et contrôle)</term><term>Infections à coronavirus (transmission)</term><term>Isolement social</term><term>Maisons de repos</term><term>Pandémies (prévention et contrôle)</term><term>Pneumopathie virale (prévention et contrôle)</term><term>Pneumopathie virale (transmission)</term><term>Sécurité des patients</term><term>Sélection de patients</term><term>Électroconvulsivothérapie (méthodes)</term><term>Électroconvulsivothérapie (normes)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term></keywords><keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Communicable Disease Control</term></keywords><keywords scheme="MESH" qualifier="législation et jurisprudence" xml:lang="fr"><term>Contrôle des maladies contagieuses</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Communicable Disease Control</term><term>Electroconvulsive Therapy</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Contrôle des maladies contagieuses</term><term>Électroconvulsivothérapie</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Électroconvulsivothérapie</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Pandemics</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Electroconvulsive Therapy</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>Hospitals, Private</term><term>Hospitals, Public</term><term>Humans</term><term>Nursing Homes</term><term>Patient Safety</term><term>Patient Selection</term><term>Practice Guidelines as Topic</term><term>Procedures and Techniques Utilization</term><term>Protective Devices</term><term>Social Isolation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Dispositifs de protection</term><term>France</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Hôpitaux privés</term><term>Hôpitaux publics</term><term>Infections à coronavirus</term><term>Isolement social</term><term>Maisons de repos</term><term>Pneumopathie virale</term><term>Sécurité des patients</term><term>Sélection de patients</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The COVID-19 pandemic has had major consequences for the organization of care. In France and around the world, centers practicing electroconvulsive therapy (ECT) have seen their activity decrease, or even stop for many reasons. In this context, maintaining or resuming this essential therapeutic activity for many patients suffering from psychiatric disorders requires material, human and logistical adaptations that should be supervised. The objective of this collective and national work is to offer simple recommendations that can be applied immediately by any healthcare establishment, public or private, practicing ECT. They are the result of feedback from multiprofessional and inter-establishment experiences. Declined in three stages, these recommendations are accompanied by a practical sheet which describes in detail the necessary conditions and prerequisites for any resumption of ECT activity.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32507557</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0013-7006</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>3S</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>L'Encephale</Title><ISOAbbreviation>Encephale</ISOAbbreviation></Journal><ArticleTitle>[Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2].</ArticleTitle><Pagination><MedlinePgn>S119-S122</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0013-7006(20)30093-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.encep.2020.05.008</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has had major consequences for the organization of care. In France and around the world, centers practicing electroconvulsive therapy (ECT) have seen their activity decrease, or even stop for many reasons. In this context, maintaining or resuming this essential therapeutic activity for many patients suffering from psychiatric disorders requires material, human and logistical adaptations that should be supervised. The objective of this collective and national work is to offer simple recommendations that can be applied immediately by any healthcare establishment, public or private, practicing ECT. They are the result of feedback from multiprofessional and inter-establishment experiences. Declined in three stages, these recommendations are accompanied by a practical sheet which describes in detail the necessary conditions and prerequisites for any resumption of ECT activity.</AbstractText><CopyrightInformation>Copyright © 2020 L'Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sauvaget</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Nantes Université, CHU Nantes, Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France. Electronic address: anne.sauvaget@chu-nantes.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumont</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>CHU de Nantes, Department of Anesthesiology and Critical Care Medicine, Hôtel-Dieu-PTMC, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bukowski</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>CHU Nantes, Department of Addictology and Psychiatry, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonnot</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Child and Adolescent Psychiatry Department, CHU and University of Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Auffret</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>CHU Nantes, Department of Addictology and Psychiatry, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poulet</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Centre hospitalier Le Vinatier, Bron, France; Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 69000 Lyon, France; University Lyon 1, 69000 Villeurbanne, France; Department of Emergency Psychiatry, hospices civils de Lyon, University Hospital Edouard-Herriot, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szekely</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Department of psychiatry, centre hospitalier Princesse-Grace, 98000 Monaco, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quiles</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre hospitalier Charles-Perrens, 33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yrondi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Service de psychiatrie et de psychologie médicale, centre expert dépression résistante fondamental, CHU de Toulouse, Toulouse, France; Inserm, UPS, ToNIC Toulouse NeuroImaging Center, hôpital Purpan, université de Toulouse, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plaze</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Université de Paris, 75005 Paris, France; Service hospitalo-universitaire, GHU de Paris psychiatrie & neurosciences, 75014 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Carvalho</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Pôle ECT - groupe SINOUÉ, clinique BELLEVUE, 92190 Meudon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amad</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Inserm, U1172 - LilNCog - Lille Neuroscience & Cognition, CHU de Lille, université de Lille, 59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulteau</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; CHU Nantes, Department of Addictology and Psychiatry, Nantes, France; Inserm-U1246 SPHERE University of Nantes and University of Tours, Nantes, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Recommandations pour une reprise progressive et contrôlée de l’électroconvulsivothérapie en France en période de levée du confinement et de pandémie COVID-19 liée au SARS-CoV-2.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Encephale</MedlineTA><NlmUniqueID>7505643</NlmUniqueID><ISSNLinking>0013-7006</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName><QualifierName UI="Q000331" MajorTopicYN="N">legislation & jurisprudence</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004565" MajorTopicYN="Y">Electroconvulsive Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016304" MajorTopicYN="N">Hospitals, Private</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006779" MajorTopicYN="N">Hospitals, Public</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009735" MajorTopicYN="N">Nursing Homes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078337" MajorTopicYN="N">Procedures and Techniques Utilization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011482" MajorTopicYN="N">Protective Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012934" MajorTopicYN="N">Social Isolation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Accessibility</Keyword><Keyword MajorTopicYN="N">Accès</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Electroconvulsive therapy</Keyword><Keyword MajorTopicYN="N">Guidelines</Keyword><Keyword MajorTopicYN="N">Recommandations</Keyword><Keyword MajorTopicYN="N">Électroconvulsivothérapie</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32507557</ArticleId><ArticleId IdType="pii">S0013-7006(20)30093-2</ArticleId><ArticleId IdType="doi">10.1016/j.encep.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7271849</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Aquitaine</li><li>Auvergne-Rhône-Alpes</li><li>Hauts-de-France</li><li>Midi-Pyrénées</li><li>Nord-Pas-de-Calais</li><li>Nouvelle-Aquitaine</li><li>Occitanie (région administrative)</li><li>Pays de la Loire</li><li>Rhône-Alpes</li><li>Île-de-France</li></region><settlement><li>Bordeaux</li><li>Lille</li><li>Lyon</li><li>Meudon</li><li>Nantes</li><li>Paris</li><li>Toulouse</li></settlement></list><tree><country name="France"><region name="Pays de la Loire"><name sortKey="Sauvaget, A" sort="Sauvaget, A" uniqKey="Sauvaget A" first="A" last="Sauvaget">A. Sauvaget</name></region><name sortKey="Amad, A" sort="Amad, A" uniqKey="Amad A" first="A" last="Amad">A. Amad</name><name sortKey="Auffret, R" sort="Auffret, R" uniqKey="Auffret R" first="R" last="Auffret">R. Auffret</name><name sortKey="Bonnot, O" sort="Bonnot, O" uniqKey="Bonnot O" first="O" last="Bonnot">O. Bonnot</name><name sortKey="Bukowski, N" sort="Bukowski, N" uniqKey="Bukowski N" first="N" last="Bukowski">N. Bukowski</name><name sortKey="Bulteau, S" sort="Bulteau, S" uniqKey="Bulteau S" first="S" last="Bulteau">S. Bulteau</name><name sortKey="De Carvalho, W" sort="De Carvalho, W" uniqKey="De Carvalho W" first="W" last="De Carvalho">W. De Carvalho</name><name sortKey="Dumont, R" sort="Dumont, R" uniqKey="Dumont R" first="R" last="Dumont">R. Dumont</name><name sortKey="Plaze, M" sort="Plaze, M" uniqKey="Plaze M" first="M" last="Plaze">M. Plaze</name><name sortKey="Poulet, E" sort="Poulet, E" uniqKey="Poulet E" first="E" last="Poulet">E. Poulet</name><name sortKey="Quiles, C" sort="Quiles, C" uniqKey="Quiles C" first="C" last="Quiles">C. Quiles</name><name sortKey="Szekely, D" sort="Szekely, D" uniqKey="Szekely D" first="D" last="Szekely">D. Szekely</name><name sortKey="Yrondi, A" sort="Yrondi, A" uniqKey="Yrondi A" first="A" last="Yrondi">A. Yrondi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidPsychoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000029 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000029 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidPsychoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32507557
|texte= [Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32507557" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidPsychoV1
| This area was generated with Dilib version V0.6.35. |  |